15-50484328-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005154.5(USP8):​c.1857T>C​(p.Phe619Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0387 in 1,611,854 control chromosomes in the GnomAD database, including 3,142 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.090 ( 1336 hom., cov: 32)
Exomes 𝑓: 0.033 ( 1806 hom. )

Consequence

USP8
NM_005154.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.15

Publications

10 publications found
Variant links:
Genes affected
USP8 (HGNC:12631): (ubiquitin specific peptidase 8) This gene encodes a protein that belongs to the ubiquitin-specific processing protease family of proteins. The encoded protein is thought to regulate the morphology of the endosome by ubiquitination of proteins on this organelle and is involved in cargo sorting and membrane trafficking at the early endosome stage. This protein is required for the cell to enter the S phase of the cell cycle and also functions as a positive regulator in the Hedgehog signaling pathway in development. Pseudogenes of this gene are present on chromosomes 2 and 6. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
USP8 Gene-Disease associations (from GenCC):
  • autosomal recessive spastic paraplegia type 59
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary spastic paraplegia
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 15-50484328-T-C is Benign according to our data. Variant chr15-50484328-T-C is described in ClinVar as Benign. ClinVar VariationId is 458314.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.243 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USP8NM_005154.5 linkc.1857T>C p.Phe619Phe synonymous_variant Exon 12 of 20 ENST00000307179.9 NP_005145.3 P40818-1A0A024R5S4A8K8N5
USP8NM_001128610.3 linkc.1857T>C p.Phe619Phe synonymous_variant Exon 12 of 20 NP_001122082.1 P40818-1A0A024R5S4
USP8NM_001283049.2 linkc.1572+2263T>C intron_variant Intron 9 of 16 NP_001269978.1 P40818-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USP8ENST00000307179.9 linkc.1857T>C p.Phe619Phe synonymous_variant Exon 12 of 20 1 NM_005154.5 ENSP00000302239.4 P40818-1

Frequencies

GnomAD3 genomes
AF:
0.0898
AC:
13656
AN:
152056
Hom.:
1335
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.247
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0559
Gnomad ASJ
AF:
0.0300
Gnomad EAS
AF:
0.0189
Gnomad SAS
AF:
0.0313
Gnomad FIN
AF:
0.0124
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0285
Gnomad OTH
AF:
0.0704
GnomAD2 exomes
AF:
0.0419
AC:
10455
AN:
249694
AF XY:
0.0389
show subpopulations
Gnomad AFR exome
AF:
0.257
Gnomad AMR exome
AF:
0.0315
Gnomad ASJ exome
AF:
0.0338
Gnomad EAS exome
AF:
0.0171
Gnomad FIN exome
AF:
0.0104
Gnomad NFE exome
AF:
0.0291
Gnomad OTH exome
AF:
0.0334
GnomAD4 exome
AF:
0.0334
AC:
48714
AN:
1459680
Hom.:
1806
Cov.:
30
AF XY:
0.0330
AC XY:
23930
AN XY:
726182
show subpopulations
African (AFR)
AF:
0.255
AC:
8473
AN:
33204
American (AMR)
AF:
0.0340
AC:
1507
AN:
44384
Ashkenazi Jewish (ASJ)
AF:
0.0356
AC:
928
AN:
26088
East Asian (EAS)
AF:
0.0142
AC:
562
AN:
39554
South Asian (SAS)
AF:
0.0305
AC:
2623
AN:
85952
European-Finnish (FIN)
AF:
0.0103
AC:
551
AN:
53384
Middle Eastern (MID)
AF:
0.0407
AC:
234
AN:
5744
European-Non Finnish (NFE)
AF:
0.0280
AC:
31164
AN:
1111082
Other (OTH)
AF:
0.0443
AC:
2672
AN:
60288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
2054
4108
6162
8216
10270
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1292
2584
3876
5168
6460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0899
AC:
13675
AN:
152174
Hom.:
1336
Cov.:
32
AF XY:
0.0876
AC XY:
6521
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.247
AC:
10242
AN:
41476
American (AMR)
AF:
0.0558
AC:
853
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0300
AC:
104
AN:
3470
East Asian (EAS)
AF:
0.0183
AC:
95
AN:
5184
South Asian (SAS)
AF:
0.0311
AC:
150
AN:
4826
European-Finnish (FIN)
AF:
0.0124
AC:
131
AN:
10604
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0285
AC:
1936
AN:
68008
Other (OTH)
AF:
0.0697
AC:
147
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
566
1133
1699
2266
2832
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0535
Hom.:
549
Bravo
AF:
0.100
Asia WGS
AF:
0.0420
AC:
147
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
8.3
DANN
Benign
0.71
PhyloP100
2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10220843; hg19: chr15-50776525; COSMIC: COSV56164513; COSMIC: COSV56164513; API